Doubt cast on anti-retroviral strategy

20 March 2006

Researchers in London, UK, are calling for changes in the way that developing countries employ anti-retroviral ther-apy to contain HIV/AIDS. Using modelling to evaluate different treatment strategies, a team from Imperial College London found that ART could encourage patients who feel better, to become more sexually active. As a result, HIV/ AIDS could spread more rapidly. The report's authors con-clude that counselling patients about risk-prevention would "ensure that limited supplies are used most effectively."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight